Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

21.3%

10 terminated/withdrawn out of 47 trials

Success Rate

73.0%

-13.5% vs industry average

Late-Stage Pipeline

6%

3 trials in Phase 3/4

Results Transparency

0%

0 of 27 completed trials have results

Key Signals

3 recruiting9 terminated

Enrollment Performance

Analytics

N/A
22(68.8%)
Phase 2
7(21.9%)
Phase 3
2(6.3%)
Phase 4
1(3.1%)
32Total
N/A(22)
Phase 2(7)
Phase 3(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (47)

Showing 20 of 47 trials
NCT05091684Phase 2Terminated

Administration of Fibrinogen Concentrate for Refractory Bleeding

Role: collaborator

NCT05130138Not ApplicableRecruiting

Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia

Role: collaborator

NCT03753776Phase 3Completed

Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women

Role: collaborator

NCT04517656Not ApplicableRecruiting

Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells

Role: collaborator

NCT03439371Not ApplicableRecruiting

Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia

Role: collaborator

NCT04250805Phase 2Terminated

Trial Evaluating the Efficacy of the Combination of ROpivacaine With Reference XYlocaine in the Evaluation of Pain During the Installation of Percutaneous Radiological GASTrostomy

Role: collaborator

NCT03240341Not ApplicableCompleted

Influence of PARAmedical Interventions on Patient ACTivation in the Cancer Care Pathway

Role: collaborator

NCT03234335Completed

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment

Role: collaborator

NCT04103359Not ApplicableTerminated

Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy

Role: collaborator

NCT03801122Phase 2Completed

Evolution of Thromboelastography During Tranexamic Acid Treatment

Role: collaborator

NCT03233074Terminated

Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors

Role: collaborator

NCT02999152Not ApplicableTerminated

Validation of Radio-induced Damage Biomarkers

Role: collaborator

NCT02994914Not ApplicableTerminated

GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance

Role: collaborator

NCT03126045Not ApplicableCompleted

A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hematology

Role: collaborator

NCT03317613Phase 2Completed

Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain

Role: collaborator

NCT03324958Not ApplicableTerminated

VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.

Role: collaborator

NCT03707301Terminated

Post-SOPHrology Cancer Patients' anxieTY Report

Role: collaborator

NCT03743961Terminated

Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia

Role: lead

NCT03323424Phase 2Withdrawn

Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers

Role: lead

NCT03675997Completed

GRAFted Patients' anxieTY Report

Role: lead